"Saint Joseph Mercy Health System (SJMHS) is a health care organization serving seven counties in southeast Michigan including Livingston, Washtenaw, Wayne, Oakland, Macomb, Jackson, and Lenawee. It includes 548-bed St. Joseph Mercy Ann Arbor, 497-bed St. Joseph Mercy Oakland in Pontiac, 304-bed St. Mary Mercy Livonia, 66-bed St. Joseph Mercy Livingston in Howell, and 133-bed St. Joseph Mercy Chelsea."

During the past decade, Saint Joseph Mercy Cancer Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 99 clinical trials were completed, i.e. on average, 2475% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 13 clinical trials were completed. i.e. 1300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Joseph Mercy Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 74 trials, followed by "SWOG Cancer Research Network" with 40 trials sponsored, "Radiation Therapy Oncology Group" with 19 trials sponsored, "Eastern Cooperative Oncology Group" with 17 trials sponsored and "NSABP Foundation Inc" with 17 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Joseph Mercy Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 170 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Cancer and Leukemia Group B" with 11 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator and "North Central Cancer Treatment Group" with 7 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Saint Joseph Mercy Cancer Center" are "Breast Cancer" (42 trials), "Lung Cancer" (32 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (14 trials), "Lymphoma" (13 trials) and "Prostate Cancer" (13 trials). Many other conditions were trialed in "Saint Joseph Mercy Cancer Center" in a lesser frequency.

Most popular intervention types in "Saint Joseph Mercy Cancer Center" are "Drug" (142 trials), "Other" (52 trials), "Biological" (48 trials), "Radiation" (39 trials) and "Procedure" (21 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (31 trials), "carboplatin" (18 trials), "radiation therapy" (18 trials), "bevacizumab" (17 trials) and "cisplatin" (16 trials). Other intervention names were less common.

The vast majority of trials in "Saint Joseph Mercy Cancer Center" are 138 trials for "All" genders, 32 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Joseph Mercy Cancer Center". undefined are not yet recruiting, 1 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 150 completed trials in Saint Joseph Mercy Cancer Center, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Joseph Mercy Cancer Center, 5 "Phase 1" clinical trials were conducted, 87 "Phase 2" clinical trials and 73 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".